Allen S. Melemed - Jan 17, 2023 Form 4 Insider Report for CHIMERIX INC (CMRX)

Signature
/s/ Michael Alrutz, Attorney-in-Fact
Stock symbol
CMRX
Transactions as of
Jan 17, 2023
Transactions value $
$0
Form type
4
Date filed
1/19/2023, 08:47 PM
Previous filing
Jan 20, 2022
Next filing
Feb 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMRX Common Stock Award $0 +25.7K +116.22% $0.00 47.9K Jan 17, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMRX Stock Option (Right to Buy) Award $0 +154K $0.00 154K Jan 17, 2023 Common Stock 154K $1.97 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares being reported are being issued pursuant to restricted stock unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 6,435 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 6,435 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 6,435 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 6,435 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant.
F2 Includes 4,345 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on March 10, 2021, 6,414 shares acquired under the ESPP on September 10, 2021, 6,707 shares acquired under the ESPP on March 10, 2022 and 4,681 shares acquired under the ESPP on September 9, 2022.
F3 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.